Patients
Patients who were followed up on for more than 48 hours in ICU and more than 72 hours in medical wards due to COVID-19 between March 19 and September 1, 2020 were included in the study. We excluded the following patients, (1) those who have neurodegenerative diseases, (2) those who were readmitted to the hospital due to any other conditions, (3) those with impaired movement due to physical disabilities. Patients were included in the study for at least 6 months, after discharge from the hospital.
The diagnosis of COVID-19 was based on World Health Organization (WHO) interim guidance18. Antiviral treatment against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was given according to Turkish Ministry of Health COVID-19 Guidance19.